RxSight (RXST) News Today $15.85 +0.87 (+5.81%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$16.02 +0.17 (+1.04%) As of 07:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period RxSight (RXST) Projected to Post Earnings on WednesdayMay 5 at 2:11 AM | americanbankingnews.com4D Advisors LLC Takes $1.89 Million Position in RxSight, Inc. (NASDAQ:RXST)4D Advisors LLC purchased a new stake in RxSight, Inc. (NASDAQ:RXST - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 55,000 shares of the company's stock, valued at approximately $1,891,000. 4D Advisors LLC ownedMay 4 at 7:25 AM | marketbeat.comSchonfeld Strategic Advisors LLC Takes Position in RxSight, Inc. (NASDAQ:RXST)Schonfeld Strategic Advisors LLC bought a new position in RxSight, Inc. (NASDAQ:RXST - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 199,400 shares of the company's stock, valued at approximately $6,855,000.May 4 at 5:16 AM | marketbeat.comRA Capital Management L.P. Decreases Stake in RxSight, Inc. (NASDAQ:RXST)RA Capital Management L.P. decreased its holdings in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 4.4% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,743,018 shares of the company's stoMay 3 at 7:48 AM | marketbeat.comRxSight (RXST) Expected to Announce Earnings on WednesdayRxSight (NASDAQ:RXST) will be releasing earnings after the market closes on Wednesday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-7-rxsight-inc-stock/)May 2 at 5:16 AM | marketbeat.comRxSight, Inc. to Present at the Bank of America Healthcare ConferenceApril 30, 2025 | globenewswire.comBrokerages Set RxSight, Inc. (NASDAQ:RXST) Price Target at $37.60April 29, 2025 | americanbankingnews.comGilder Gagnon Howe & Co. LLC Reduces Stock Holdings in RxSight, Inc. (NASDAQ:RXST)Gilder Gagnon Howe & Co. LLC reduced its stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 27.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 425,322 shares of the company's stock after seApril 28, 2025 | marketbeat.comRussell Investments Group Ltd. Sells 94,412 Shares of RxSight, Inc. (NASDAQ:RXST)Russell Investments Group Ltd. reduced its position in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 98.4% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,566 shares of the company's stock after selling 94,412April 28, 2025 | marketbeat.comJPMorgan Chase & Co. Reduces Stake in RxSight, Inc. (NASDAQ:RXST)JPMorgan Chase & Co. lessened its position in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 82.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 34,397 shares of the company's stock after selling 158,113 shares during the quaApril 28, 2025 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Given Average Recommendation of "Hold" by BrokeragesShares of RxSight, Inc. (NASDAQ:RXST - Get Free Report) have been assigned an average recommendation of "Hold" from the ten brokerages that are presently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell rating, four have given a hold raApril 28, 2025 | marketbeat.comOberweis Asset Management Inc. Sells 107,600 Shares of RxSight, Inc. (NASDAQ:RXST)Oberweis Asset Management Inc. cut its holdings in RxSight, Inc. (NASDAQ:RXST - Free Report) by 85.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 19,040 shares of the company's stock after selling 107,600 sharesApril 27, 2025 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Shares Sold by Invesco Ltd.Invesco Ltd. reduced its stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 60.4% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 391,163 shares of the company's stock after selling 596,434 shares during the periodApril 23, 2025 | marketbeat.comWalleye Capital LLC Has $1.08 Million Stock Position in RxSight, Inc. (NASDAQ:RXST)Walleye Capital LLC lessened its stake in RxSight, Inc. (NASDAQ:RXST - Free Report) by 75.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 31,342 shares of the company's stock after sellApril 22, 2025 | marketbeat.comFederated Hermes Inc. Sells 63,118 Shares of RxSight, Inc. (NASDAQ:RXST)Federated Hermes Inc. reduced its holdings in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 91.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,146 shares of the company's stock after sellinApril 21, 2025 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Stock Holdings Increased by Jump Financial LLCJump Financial LLC lifted its position in RxSight, Inc. (NASDAQ:RXST - Free Report) by 57.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 93,255 shares of the company's stock after acquiring anApril 20, 2025 | marketbeat.comAltium Capital Management LLC Boosts Stock Position in RxSight, Inc. (NASDAQ:RXST)Altium Capital Management LLC lifted its stake in RxSight, Inc. (NASDAQ:RXST - Free Report) by 154.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 285,000 shares of the company's stock after acquiring an additiApril 19, 2025 | marketbeat.comOsterweis Capital Management Inc. Grows Position in RxSight, Inc. (NASDAQ:RXST)Osterweis Capital Management Inc. boosted its holdings in RxSight, Inc. (NASDAQ:RXST - Free Report) by 48.3% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 288,072 shares of the company's stock after buying an additional 93,827 shares duriApril 19, 2025 | marketbeat.comWasatch Advisors LP Acquires 103,856 Shares of RxSight, Inc. (NASDAQ:RXST)Wasatch Advisors LP increased its holdings in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 50.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 310,596 shares of the company's stock after purApril 19, 2025 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Stock Position Lifted by Renaissance Technologies LLCRenaissance Technologies LLC boosted its stake in RxSight, Inc. (NASDAQ:RXST - Free Report) by 102.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 361,500 shares of the company's stock afteApril 18, 2025 | marketbeat.comRxSight (NASDAQ:RXST) Shares Gap Down - Time to Sell?RxSight (NASDAQ:RXST) Shares Gap Down - Here's What HappenedApril 17, 2025 | marketbeat.comRxSight (NASDAQ:RXST) Coverage Initiated by Analysts at Piper SandlerPiper Sandler started coverage on shares of RxSight in a research report on Tuesday. They issued a "neutral" rating and a $18.00 target price on the stock.April 17, 2025 | marketbeat.comPiper Sandler Initiates Coverage of RxSight (RXST) with Neutral RecommendationApril 16, 2025 | msn.comRxSight initiated with a Neutral at Piper SandlerApril 15, 2025 | markets.businessinsider.comNext Century Growth Investors LLC Sells 405,554 Shares of RxSight, Inc. (NASDAQ:RXST)Next Century Growth Investors LLC lowered its stake in RxSight, Inc. (NASDAQ:RXST - Free Report) by 70.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 170,899 shares of the company's stApril 14, 2025 | marketbeat.comGrandeur Peak Global Advisors LLC Takes $2.91 Million Position in RxSight, Inc. (NASDAQ:RXST)Grandeur Peak Global Advisors LLC purchased a new stake in RxSight, Inc. (NASDAQ:RXST - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 84,560 shares of the company's stock, valued at approximately $2,907,000. Grandeur PeaApril 14, 2025 | marketbeat.comRxSight (NASDAQ:RXST) Hits New 1-Year Low - Here's WhyRxSight (NASDAQ:RXST) Sets New 52-Week Low - Should You Sell?April 12, 2025 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Shares Purchased by Vanguard Group Inc.Vanguard Group Inc. increased its stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 4.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,383,548 shares of the company's stock after buyingApril 12, 2025 | marketbeat.comRxSight (NASDAQ:RXST) Shares Gap Down - What's Next?RxSight (NASDAQ:RXST) Shares Gap Down - What's Next?April 11, 2025 | marketbeat.comRxSight (NASDAQ:RXST) Downgraded to Neutral Rating by UBS GroupUBS Group downgraded shares of RxSight from a "buy" rating to a "neutral" rating and set a $16.00 price objective for the company. in a research report on Wednesday.April 11, 2025 | marketbeat.comTrexquant Investment LP Reduces Stock Holdings in RxSight, Inc. (NASDAQ:RXST)Trexquant Investment LP reduced its stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 57.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 56,416 shares of the company's stock after sellingApril 11, 2025 | marketbeat.comRxSight (NASDAQ:RXST) Shares Down 11.3% - Time to Sell?RxSight (NASDAQ:RXST) Shares Down 11.3% - Time to Sell?April 10, 2025 | marketbeat.comRxSight downgraded to Neutral from Buy at UBSApril 10, 2025 | markets.businessinsider.comUBS Downgrades RxSight (RXST)April 10, 2025 | msn.comRxSight price target lowered to $17 from $22 at Wells FargoApril 7, 2025 | msn.comAmerican Century Companies Inc. Sells 125,757 Shares of RxSight, Inc. (NASDAQ:RXST)American Century Companies Inc. lowered its position in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 50.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 123,805 shares of the cApril 7, 2025 | marketbeat.comRxSight (NASDAQ:RXST) Given "Underweight" Rating at JPMorgan Chase & Co.JPMorgan Chase & Co. reiterated an "underweight" rating and set a $17.00 target price (down from $40.00) on shares of RxSight in a research report on Friday.April 6, 2025 | marketbeat.comRxSight (NASDAQ:RXST) Reaches New 12-Month Low on Analyst DowngradeRxSight (NASDAQ:RXST) Reaches New 12-Month Low on Analyst DowngradeApril 5, 2025 | marketbeat.comWells Fargo & Company Lowers RxSight (NASDAQ:RXST) Price Target to $22.00Wells Fargo & Company reduced their price objective on RxSight from $35.00 to $22.00 and set an "equal weight" rating on the stock in a report on Thursday.April 5, 2025 | marketbeat.comRxSight (NASDAQ:RXST) Receives "Underperform" Rating from Bank of AmericaBank of America restated an "underperform" rating and issued a $22.00 price target (down from $36.00) on shares of RxSight in a report on Thursday.April 5, 2025 | marketbeat.comJP Morgan Downgrades RxSight (RXST)April 5, 2025 | msn.comRxSight (NASDAQ:RXST) Receives "Buy" Rating from Needham & Company LLCNeedham & Company LLC reissued a "buy" rating and issued a $43.00 target price on shares of RxSight in a research note on Thursday.April 5, 2025 | marketbeat.com422,446 Shares in RxSight, Inc. (NASDAQ:RXST) Acquired by DF Dent & Co. Inc.DF Dent & Co. Inc. bought a new position in RxSight, Inc. (NASDAQ:RXST - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund bought 422,446 shares of the company's stock, valued at approximately $14,524,000. DF Dent & Co. Inc. owned 1.05April 5, 2025 | marketbeat.com5RXST : Deep Dive Into RxSight Stock: Analyst Perspectives (12...April 4, 2025 | benzinga.comRxSight downgraded to Underweight from Overweight at JPMorganApril 4, 2025 | markets.businessinsider.com​RxSight: Navigating Market Headwinds Amid Intensifying Competition (Downgrade)April 3, 2025 | seekingalpha.comRxsight adjusts 2025 revenue guidance to $160M-$175M amid premium IOL market challengesApril 3, 2025 | msn.comRxSight plunges after guidance cut; BofA downgradesApril 3, 2025 | msn.comRxSight, Inc. (RXST) Q1 2025 Preliminary Results Conference Call (Transcript)April 3, 2025 | seekingalpha.comRxSight cuts FY25 revenue view to $160M-$175M from $185M-$197MApril 3, 2025 | markets.businessinsider.com Get RxSight News Delivered to You Automatically Sign up to receive the latest news and ratings for RXST and its competitors with MarketBeat's FREE daily newsletter. Email Address RXST Media Mentions By Week RXST Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RXST News Sentiment▼1.060.73▲Average Medical News Sentiment RXST News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RXST Articles This Week▼76▲RXST Articles Average Week Get RxSight News Delivered to You Automatically Sign up to receive the latest news and ratings for RXST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LeMaitre Vascular News NovoCure News LivaNova News Enovis News Warby Parker News CONMED News Kestra Medical Technologies News Pulse Biosciences News Cadre News Tandem Diabetes Care News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RXST) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RxSight, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RxSight With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RXST Stock Free RXST Stock Alerts